{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:09:52Z","timestamp":1791835792472,"version":"4.3.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2004,9,10]],"date-time":"2004-09-10T00:00:00Z","timestamp":1094774400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1038\/sj.eye.6701632","type":"journal-article","created":{"date-parts":[[2004,9,10]],"date-time":"2004-09-10T09:54:40Z","timestamp":1094810080000},"page":"739-742","source":"Crossref","is-referenced-by-count":23,"title":["A randomised, double-blind trial of topical ketorolac vs artificial tears for the treatment of episcleritis"],"prefix":"10.1038","volume":"19","author":[{"given":"C P R","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A C","family":"Browning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T J","family":"Sleep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S K","family":"Webber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J I","family":"McGill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,9,10]]},"reference":[{"key":"BF6701632_CR1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0161-6420(99)90157-4","volume":"106","author":"EK Akpek","year":"1999","unstructured":"Akpek EK, Uy HS, Christen W, Gurdal C, Foster CS . Severity of episcleritis and systemic disease. Ophthalmology 1999; 106: 729\u2013731.","journal-title":"Ophthalmology"},{"key":"BF6701632_CR2","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1136\/bjo.57.11.866","volume":"57","author":"PG Watson","year":"1973","unstructured":"Watson PG, McKay DAR, Clemett RS, Wilkinson P . Treatment of episcleritis. A double-blind trial comparing betamethasone 0.1 percent, oxyphenbutazone 10 per cent, and placebo eye ointments. Br J Ophthalmol 1973; 57: 866\u2013870.","journal-title":"Br J Ophthalmol"},{"key":"BF6701632_CR3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/eye.1990.69","volume":"4","author":"CJ Lyons","year":"1990","unstructured":"Lyons CJ, Hakin KN, Watson PG . Topical flurbiprofen: an effective treatment for episcleritis? Eye 1990; 4: 521\u2013525.","journal-title":"Eye"},{"key":"BF6701632_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1136\/bjo.65.9.641","volume":"65","author":"D Lloyd-Jones","year":"1981","unstructured":"Lloyd-Jones D, Tokarewicz, Watson PG . Clinical evaluation of clobetasone butyrate eye drops in episcleritis. Br J Ophthalmol 1981; 65: 641\u2013643.","journal-title":"Br J Ophthalmol"},{"key":"BF6701632_CR5","volume-title":"Clinical Ophthalmology","author":"PG Watson","year":"1987","unstructured":"Watson PG . Diseases of the sclera and episclera. In: Duane TD (ed). Clinical Ophthalmology, Vol 4. Chapter 23, Harper and Row: Philadelphia, 1987."},{"key":"BF6701632_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/bjo.50.8.463","volume":"50","author":"PG Watson","year":"1966","unstructured":"Watson PG, Lobascher DJ, Sabiston DW, Lewis-Faning E, Fowler PD, Jones BR . Double-blind trial of the treatment of episcleritis\u2014scleritis with oxyphenbutazone or prednisolone. Br J Ophthalmol 1966; 50: 463\u2013481.","journal-title":"Br J Ophthalmol"},{"key":"BF6701632_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0002-9394(98)00413-9","volume":"127","author":"J Heier","year":"1999","unstructured":"Heier J, Cheetham JK, Degryse R, Dirks MS, Caldwell DR, Silverstone DE et al. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicl-controlled clinical trial. Am J Ophthalmol 1999; 127: 253\u2013259.","journal-title":"Am J Ophthalmol"},{"key":"BF6701632_CR8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3928\/1542-8877-19980701-03","volume":"29","author":"SM El-Harazi","year":"1998","unstructured":"El-Harazi SM, Ruiz RS, Feldman RM, Villanueva G, Chuang AZ . A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells. Ophthalmic Surg Lasers 1998; 29: 539\u2013544.","journal-title":"Ophthalmic Surg Lasers"},{"issue":"Supp","key":"BF6701632_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0039-6257(93)90037-8","volume":"38","author":"DG Tinkleman","year":"1993","unstructured":"Tinkleman DG, Rupp G, Kaufman H, Pugley J, Schultz N . Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol 1993; 38 (Supp): 133\u2013140.","journal-title":"Surv Ophthalmol"},{"issue":"Supp","key":"BF6701632_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0039-6257(93)90038-9","volume":"38","author":"Z Ballas","year":"1993","unstructured":"Ballas Z, Blumenthal M, Tinkleman DG, Kriz R, Rupp G . Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol 1993; 38 (Supp): 141\u2013148.","journal-title":"Surv Ophthalmol"},{"key":"BF6701632_CR11","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/eye.1991.125","volume":"5","author":"CSC Liu","year":"1991","unstructured":"Liu CSC, Ramirez-Florez S, Watson PG . A randomised double blind trial comparing the treatment of episcleritis with topical 2-(2-hydroxy-4-methylphenyl) aminothiazole hydrochloride 0.1% (CBS 113A) and placebo. Eye 1991; 5: 678\u2013685.","journal-title":"Eye"},{"key":"BF6701632_CR12","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/archopht.1997.01100160289004","volume":"115","author":"KD Solomon","year":"1997","unstructured":"Solomon KD, Turkalj JW, Whiteside SB, Stewart JA, Apple DJ . Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery. Arch Ophthalmol 1997; 115: 1119\u20131122.","journal-title":"Arch Ophthalmol"},{"key":"BF6701632_CR13","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S0161-6420(97)30135-3","volume":"104","author":"PK Kaiser","year":"1997","unstructured":"Kaiser PK, Pineda R . A study of topical nonsteroidal anti-inflammatory drops and no pressure patching in the treatment of corneal abrasions. Ophthalmology 1997; 104: 1353\u20131359.","journal-title":"Ophthalmology"},{"key":"BF6701632_CR14","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S0886-3350(99)00116-9","volume":"25","author":"MB McDonald","year":"1999","unstructured":"McDonald MB, Brint SF, Caplan DI, Bourque LB, Shoaf K . Comparison of ketorolac tromethamine, diclofenac sodium, and moist drops for ocular pain after radial keratotomy. J Cataract Refract Surg 1999; 25: 1097\u20131108.","journal-title":"J Cataract Refract Surg"},{"issue":"4","key":"BF6701632_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0039-6257(92)90095-B","volume":"36","author":"AJ Flach","year":"1992","unstructured":"Flach AJ . Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol 1992; 36 (4): 259\u2013284.","journal-title":"Surv Ophthalmol"},{"key":"BF6701632_CR16","unstructured":"Summary of product characteristics. Allergan 2001."},{"issue":"11","key":"BF6701632_CR17","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1016\/S0161-6420(00)00365-1","volume":"107","author":"JS Heier","year":"2000","unstructured":"Heier JS, Topping TM, Baumann W, Dirks MS, Chern S . Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic macular edema. Ophthalmology 2000; 107 (11): 2034\u20132038.","journal-title":"Ophthalmology"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6701632.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701632","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701632.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:18:19Z","timestamp":1684412299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6701632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,10]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["BF6701632"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6701632","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,10]]}}}